Company Profile

Nawgen LLC
Profile last edited on: 7/13/20      CAGE: 6SUF4      UEI: QYK8WGNJJ5T8

Business Identifier: Technology for RNA research
Year Founded
2012
First Award
2015
Latest Award
2018
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4320 Forest Park Avenue Suite 303
Saint Louis, MO 63108
   (314) 485-9642
   info@nawgen.com
   www.nawgen.com
Location: Single
Congr. District: 01
County: St. Louis city

Public Profile

Nawgen, LLC is a biotech company that focuses on providing innovative solutions and cutting-edge RNA technology to life science research institutions, and Biotech and Pharmaceutical industries. Nawgen provides a variety of RNA products, including highly sensitive and specific miRNA qPCR assays, highly potent and specific miRNA CRISPR assays, highly specific and potent siRNA assays, and uniquely designed miRNA mimics.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2018 1 NIH $223,896
Project Title: Improving the Design of CRISPR/Cas9 Knockout Assays
2016 2 NIH $697,079
Project Title: Rational Design of Small Interfering RNA for Genome-Wide Target Knockdown
2015 1 NIH $224,951
Project Title: New Assays for Expression Profiling of Micrornas

Key People / Management

  Weijun Liu

  Xiaowei Wang

Company News

There are no news available.